176 related articles for article (PubMed ID: 19486933)
1. Application of melt granulation technology to enhance stability of a moisture sensitive immediate-release drug product.
Kowalski J; Kalb O; Joshi YM; Serajuddin AT
Int J Pharm; 2009 Oct; 381(1):56-61. PubMed ID: 19486933
[TBL] [Abstract][Full Text] [Related]
2. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
3. Optimization of melt pelletization in a high shear mixer.
Bukovec P; Kroselj V; Turk S; Vrecer F
Int J Pharm; 2009 Nov; 381(2):192-8. PubMed ID: 19580855
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of drug physical form during granulation, tabletting and storage.
Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW
Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136
[TBL] [Abstract][Full Text] [Related]
5. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
6. Solid-state interaction of stearic acid with povidone and its effect on dissolution stability of capsules.
Desai D; Kothari S; Huang M
Int J Pharm; 2008 Apr; 354(1-2):77-81. PubMed ID: 18194844
[TBL] [Abstract][Full Text] [Related]
7. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
8. Melt granulation in fluidized bed: a comparative study of spray-on versus in situ procedure.
Mašić I; Ilić I; Dreu R; Ibrić S; Parojčić J; Srčič S
Drug Dev Ind Pharm; 2014 Jan; 40(1):23-32. PubMed ID: 23294368
[TBL] [Abstract][Full Text] [Related]
9. Influence of binder properties, method of addition, powder type and operating conditions on fluid-bed melt granulation and resulting tablet properties.
Abberger T
Pharmazie; 2001 Dec; 56(12):949-52. PubMed ID: 11802658
[TBL] [Abstract][Full Text] [Related]
10. An investigation into the effect of formulation variables and process parameters on characteristics of granules obtained by in situ fluidized hot melt granulation.
Mašić I; Ilić I; Dreu R; Ibrić S; Parojčić J; Durić Z
Int J Pharm; 2012 Feb; 423(2):202-12. PubMed ID: 22197773
[TBL] [Abstract][Full Text] [Related]
11. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; Remon JP; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2007 Nov; 67(3):715-24. PubMed ID: 17537625
[TBL] [Abstract][Full Text] [Related]
12. Application of on-line Raman spectroscopy for characterizing relationships between drug hydration state and tablet physical stability.
Hausman DS; Cambron RT; Sakr A
Int J Pharm; 2005 Aug; 299(1-2):19-33. PubMed ID: 15979262
[TBL] [Abstract][Full Text] [Related]
13. Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation.
Rahman BM; Ibne-Wahed MI; Khondkar P; Ahmed M; Islam R; Barman RK; Islam MA
Pak J Pharm Sci; 2008 Oct; 21(4):455-9. PubMed ID: 18930870
[TBL] [Abstract][Full Text] [Related]
14. Development of manufacturing method for rapidly disintegrating oral tablets using the crystalline transition of amorphous sucrose.
Sugimoto M; Narisawa S; Matsubara K; Yoshino H; Nakano M; Handa T
Int J Pharm; 2006 Aug; 320(1-2):71-8. PubMed ID: 16750604
[TBL] [Abstract][Full Text] [Related]
15. Effect of moisture content, temperature and exposure time on the physical stability of chitosan powder and tablets.
Viljoen JM; Steenekamp JH; Marais AF; Kotzé AF
Drug Dev Ind Pharm; 2014 Jun; 40(6):730-42. PubMed ID: 23596972
[TBL] [Abstract][Full Text] [Related]
16. The influence of various amphiphilic excipients on the physicochemical properties of carbamazepine-loaded microparticles.
Barakat NS; Elanazi FK; Almurshedi AS
J Microencapsul; 2009 May; 26(3):251-62. PubMed ID: 18686144
[TBL] [Abstract][Full Text] [Related]
17. The preparation of orally disintegrating tablets using a hydrophilic waxy binder.
Abdelbary G; Prinderre P; Eouani C; Joachim J; Reynier JP; Piccerelle P
Int J Pharm; 2004 Jul; 278(2):423-33. PubMed ID: 15196646
[TBL] [Abstract][Full Text] [Related]
18. [Influence of excipients on moisture absorption and dispersibility of Shuanghuanglian microcapsules].
Liu Y; Xu DS; Feng Y; Shen L
Zhong Yao Cai; 2007 Apr; 30(4):458-60. PubMed ID: 17674802
[TBL] [Abstract][Full Text] [Related]
19. Use of calcined Mg-Al-hydrotalcite to enhance the stability of celecoxib in the amorphous form.
Ambrogi V; Perioli L; Marmottini F; Rossi C
Eur J Pharm Biopharm; 2007 May; 66(2):253-9. PubMed ID: 17123798
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a drug with wax-like properties as a melt binder.
Dhumal RS; Shimpi SL; Chauhan B; Mahadik KR; Paradkar A
Acta Pharm; 2006 Dec; 56(4):451-61. PubMed ID: 19839137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
